NCT00302458View on ClinicalTrials.gov

A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Healthy
Interventions
DRUG

OROS-Methylphenidate

Each dose of OROS MPH will be 72 mg which will be supplied as two 36 mg overencapsulated capsules

DRUG

Immediate Release Methylphenidate

Each dose of IR MPH will be 40 mg which will be supplied as two 20 mg overencapsulated capsules

DRUG

Placebo

Placebo will be administered during the first part of the day, and again during the second part of the day.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Ortho-McNeil Janssen Scientific Affairs, LLC

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00302458 - A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults | Biotech Hunter | Biotech Hunter